Clinical Trials
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar
First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...
June 01, 2021 | News
Liminal BioSciences Update Clinical Activities for Fezagepras
Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...
May 31, 2021 | News
Vietnam's Coronavirus immunization set to start stage 3 preliminaries in June
This follows promising outcomes found in the initial two stages. The Public Morals Council in Biomedical Exploration under the Service of Wellbein...
May 29, 2021 | News
Gannex Received China IND Approval
Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-...
May 28, 2021 | News
Boehringer Ingelheim's Receives FDA Breakthrough for CONNEX trial program
BI 425809, A Novel Glycine transporter-1 (GlyT1) Inhibitor To Be Studied in First-of-its-Kind Phase III Trials, Incorporating Speech Analytics and Virtual ...
May 25, 2021 | News
Agilex Biolabs Partners with Endpoints News for Clinical Trials
Agilex Biolabs' Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) said:"Inflammation is a complex biological process involving...
May 21, 2021 | News
Achiko completes initial shipment of AptameX to Indonesia
Production of first 1,000 AptameX test kits is concluded in Singapore (initial capacity to test 10,000 patients per day). AptameX delivers sensitivity o...
May 20, 2021 | News
Nanoform’s final clinical results confirm value proposition to the pharma industry
Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical s...
May 18, 2021 | News
Sanofi and GSK COVID-19 vaccine shows strong immunity in all age variants
Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups High immune response after a ...
May 17, 2021 | News
Phebra's Confirm Bioequivalence of Oral and IV Formulations
Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP43...
May 14, 2021 | News
Merck’s Focus on Cancer
Merck Highlights Scientific Data at 2021 ASCO Annual Meeting Across More Than 20 Cancer Types From Broad Oncology Research Program Merck (NYSE: MR...
May 13, 2021 | News
Advancing gene therapy by solving challenges in scale-up & manufacturing
Dr. Brophy shares additional insight about how producing viral vectors can be made more efficient, the lessons that can be learned from manufacturing mAbs ...
May 11, 2021 | Influencers
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
